Correction: Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Haemostasis and Thrombosis

Baker, Ross I; Coughlin, Paul B; Salem, Hatem H; Gallus, Alex S; Harper, Paul L; Wood, Erica M

doi:10.5694/j.1326-5377.2005.tb06567.x

Topics

Re: “Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Haemostasis and Thrombosis”, by Ross I Baker, Paul B Coughlin, Alex S Gallus, et al on behalf of the Warfarin Reversal Consensus Group (Med J Aust 2004; 181: 492-497). In Box 5, an asterisk in the Box title should have attributed Prothombinex-HT to CSL Limited, the manufacturer of all plasma-derived therapeutic products fractionated from Australian plasma.

1 Thrombosis and Haemophilia Service, Royal Perth Hospital, Perth, WA.
2 Monash University, Box Hill Hospital, Box Hill, VIC.
3 SouthPath, Flinders Medical Centre, Bedford Park, SA.
4 Auckland City Hospital, Auckland, New Zealand.
5 Australian Red Cross Blood Service, Southbank, VIC.

Correspondence:

Online responses are no longer available. Please refer to our instructions for authors page for more information.